Market cap
₹182 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
198.4
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -5.03 | 8.95 | -- |
| EBIT | 18.22 | -22.93 | -56.49 | -215.82 | -227.29 |
| Net Profit | 8.37 | -28.57 | -4.05 | 132.08 | 63.53 |
| EPS | 8.37 | -28.57 | -4.05 | 280.72 | 39.80 |
| Book Value | -- | -- | 0.49 | 20.99 | 14.78 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| -10.53 | -5.72 | -- | -29.06 | -- |
| Net Margin
| 12.25 | 17.30 | 50.49 | 4.22 | -- |
| Return on equity
| 1.66 | 3.36 | 0.66 | 0.53 | -- |
| Return on Capital
| 0.92 | 2.56 | -- | 0.15 | -- |
| Return on Assets
| 0.61 | 2.66 | 0.65 | 0.06 | -- |
| Debt to Equity (x)
| -- | -- | 0.00 | 4.74 | -- |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
0.15
|
--
|
--
|
--
|
|
Peer Median
|
--
|
10.67
|
24.98
|
20.19
|
--
|
ROE
0.66
Lower than Peers by 9.69
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
0.66
|
0.53
|
--
|
--
|
--
|
|
Peer Median
|
10.35
|
7.59
|
20.21
|
19.34
|
--
|
ROA
0.65
Lower than Peers by 5.76
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
0.65
|
0.06
|
--
|
--
|
--
|
|
Peer Median
|
6.41
|
5.44
|
12.91
|
11.01
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
-29.06
|
--
|
--
|
--
|
|
Peer Median
|
11.02
|
11.66
|
11.54
|
15.47
|
--
|
Net Margin
50.49
Higher than Peers by 42.67
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
50.49
|
4.22
|
--
|
--
|
--
|
|
Peer Median
|
7.82
|
7.57
|
9.71
|
10.37
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
8.95
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.59
|
9.11
|
-10.85
|
39.46
|
--
|
Net Profit Growth
-4.05
Lower than Peers by 5.01
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
-4.05
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.96
|
16.56
|
-31.20
|
77.33
|
--
|
EPS Growth
-4.05
Lower than Peers by 3.99
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
-4.05
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-0.06
|
20.92
|
--
|
80.00
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
4.74
|
--
|
--
|
--
|
|
Peer Median
|
0.04
|
0.07
|
0.15
|
0.25
|
--
|
Current Ratio
15.44
Higher than Peers by 13.74
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
15.44
|
126.73
|
--
|
--
|
--
|
|
Peer Median
|
1.70
|
1.68
|
1.57
|
1.55
|
--
|
Quick Ratio
15.44
Higher than Peers by 14.44
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
15.44
|
126.73
|
--
|
--
|
--
|
|
Peer Median
|
1.01
|
1.31
|
1.19
|
0.97
|
--
|
Interest Coverage
178.60
Higher than Peers by 168.53
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
178.60
|
32.06
|
--
|
--
|
--
|
|
Peer Median
|
10.07
|
7.47
|
19.21
|
17.50
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
1.58
|
--
|
--
|
--
|
|
Peer Median
|
13.15
|
14.65
|
12.34
|
12.61
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
0.01
|
--
|
--
|
--
|
|
Peer Median
|
0.79
|
0.86
|
0.92
|
1.17
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
5.76
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
24.99
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
-19.23
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
198.42
Higher than Peers by 169.11
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
198.42
|
1,108.03
|
--
|
--
|
--
|
|
Peer Median
|
29.32
|
40.01
|
28.36
|
14.07
|
--
|
Price / Book Value
1.29
Lower than Peers by 0.98
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
1.29
|
5.90
|
--
|
--
|
--
|
|
Peer Median
|
2.27
|
1.93
|
2.13
|
2.38
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
--
|
0.04
|
--
|
--
|
--
|
|
Peer Median
|
0.43
|
0.27
|
0.45
|
0.44
|
--
|
EV/EBITDA
147.30
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
147.30
|
639.59
|
--
|
--
|
--
|
|
Peer Median
|
--
|
22.60
|
12.16
|
12.87
|
--
|
Market Cap
182
Lower than Peers by 1,611
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
ZR2 Bioenergy
|
182
|
100
|
--
|
--
|
--
|
|
Peer Median
|
1,793
|
1,454
|
1,457
|
1,879
|
--
|